ELOX
ELOXX PHARMACEUTICALS INC by Eloxx Pharmaceuticals, Inc. (ELOX)
$89
About ELOXX PHARMACEUTICALS INC by Eloxx Pharmaceuticals, Inc. (ELOX)
Eloxx Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of novel ribonucleic acid-modulating drug candidates. It focuses on the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Arlington, MA.
Details
Daily high
$14.28
Daily low
$12.90
Price at open
$13.98
52 Week High
$17.50
52 Week Low
$0.00
Market cap
586,300
Dividend yield
0.00%
Volume
14,353
Avg. volume
45,502
P/E ratio
--
ELOXX PHARMACEUTICALS INC by Eloxx Pharmaceuticals, Inc. News
Details
Daily high
$14.28
Daily low
$12.90
Price at open
$13.98
52 Week High
$17.50
52 Week Low
$0.00
Market cap
586,300
Dividend yield
0.00%
Volume
14,353
Avg. volume
45,502
P/E ratio
--